PTGS2 and breast carcinoma: As shown in Fig.S7A, we found COX-2 to be over-expressed in celecoxib-resistant cell line compared with their parental counterparts, which is consistent with a previous study where COX-2 was overexpressed during the selection of celecoxib-resistant clones in aggressive breast cancer cell lines [28].